News

Biliary Tract Infection in Patients with Acute Biliary Pancreatitis . Boudewijn De Waele, Yves Van Nieuwenhove, Sabine Lauwers, Georges Delvaux. Disclosures. In This Article.
Compared with other maternal infections, intestinal infection and genitourinary tract infection increased the risk for biliary atresia. Antepartum viral enterocolitis also increased risk.
Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa.
Acute cholangitis is a severe, bacterial infection of the biliary tract precipitated by an obstruction that often results in systemic inflammation and, in some cases, life‐threatening sepsis.
Serious AEs occurred in 53% of patients and included biliary obstruction (15%), biliary tract infection and sepsis (each in 8%), pneumonia (5%), diarrhea and gastric obstruction ...
Patients with biliary tract cancer often receive antibiotics to treat infection that occurs as a result of biliary tract obstruction, Aiwu Ruth He, MD, PhD, associate professor in the division of ...
Medically reviewed by Jay N. Yepuri, MD Primary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is a chronic and progressive disease that damages and can eventually destroy the ...
The incidence rate of biliary tract cancer varies according to geographical regions and subgroups. In recent years, the global prevalence of ICC has increased from 0.44 to 1.18 cases per 100,000 ...
On November 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to the drug zanidatamab (Ziihera ®) to treat advanced and metastatic bile duct cancer (cholangiocarcinoma) and ...
Biliary tract cancer (BTC), ... Higher rates in Asian-Pacific countries have been attributed to infection with the parasite liver flukes in several Asian countries.
Biliary Tract Infection in Patients with Acute Biliary Pancreatitis . Boudewijn De Waele, Yves Van Nieuwenhove, Sabine Lauwers, Georges Delvaux. Disclosures. In This Article.